Tyrosine kinase inhibitors as an alternative treatment in canine mast cell tumor

Tyrosine kinase inhibitors as an alternative treatment in canine mast cell tumor

The current gold standard treatment for canine mast cell tumors (MCT) uses vinblastine sulfate (VBL) as chemotherapy, although tyrosine kinase inhibitors (TKI) have recently been shown to be worthy candidates for treatment. This systematic review aimed to analyze the overall survival (OS), progressi...

Full description

Bibliographic Details
Main Authors: Yasmin Nascimento Bernardes Coelho, Luiz Ricardo Soldi, Paulo Henrique Rosa da Silva, Caio Melo Mesquita, Luiz Renato Paranhos, Thaísa Reis dos Santos, Marcelo José Barbosa Silva
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Veterinary Science
Subjects:
mast cell tumor
tyrosine kinase inhibitors
vinblastine
targets therapy
dogs
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2023.1188795/full

Internet

https://www.frontiersin.org/articles/10.3389/fvets.2023.1188795/full

Similar Items